A new law could eliminate a pitfall common in collaborative research—the potential for creating prior art against one's own research.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
122 F.3d 1396 (Fed. Cir. 1997).
Chisum, D.S. Chisum on Patents §3.08[2][a] (LexisNexis Matthew Bender, 2002), citing In re Land, 386 F.2d 866, 151 USPQ 621 (CCPA 1966).
Steffe, E.K. et al. Biotech collaborations and maximizing patent protection: Two hypotheticals. 27 AIPLA Q. J. 149 (1999).
The Honorable Lamar Smith, Remarks at the University of Texas Advanced Technology Program: Bridging the Gap Between the Research Lab and the Market Place (27 February 2004).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Thorne, L., Ergenzinger, E. & Spruill, W. Collaborative research presents special problems for patent seekers. Nat Biotechnol 22, 901–902 (2004). https://doi.org/10.1038/nbt0704-901
Issue Date:
DOI: https://doi.org/10.1038/nbt0704-901
This article is cited by
-
The CREATE Act: increasing costs associated with the biotech industry?
Nature Biotechnology (2006)
